China BCT Announces Conference Call to Discuss Fourth Quarter and Full Year 2011 Results

LIUZHOU, China, March 28, 2012 /PRNewswire-Asia/ -- China BCT Pharmacy Group, Inc., (OTC BB: CNBI), ("China BCT" or the "Company"), a leading pharmaceutical distributor, retail pharmacy, and manufacturer of pharmaceutical products in Guangxi Province, China, today announced that it will conduct a conference call at 8:00 a.m. Eastern Time on Friday, March 30, 2012 to discuss its fourth quarter and full year 2011 results.

Mr. Hui Tian Tang, Chief Executive Officer of the Company, and Ms. Shelly Zhang, Chief Financial Officer of the Company, will host the conference call. The Company will release its financial results for the fourth quarter and full year 2011 prior to the call.

The conference call can be accessed by dialing 866-759-2078 (U.S. and Canada callers) or 706-643-0585 (international callers) and entering the conference ID 65662139 approximately five to ten minutes prior to the call. A replay will be available for two weeks starting on Friday, March 30, 2012 at 11:00 a.m. ET by dialing 855-859-2056 (U.S. and Canada callers) or 404-537-3406 (international callers) and entering the conference replay ID 65662139.

About China BCT

China BCT is engaged in pharmaceutical distribution, pharmacy retailing, and the manufacture of pharmaceuticals products through its subsidiaries Guangxi Liuzhou Baicaotang Medicine Limited, Guangxi Liuzhou Baicaotang Medicine Retail Limited, and Hefeng Pharmaceutical Co. Limited in Guangxi province, China. It operates a large regional retail network in Guangxi province, consisting of 219 directly owned retail stores in Guangxi province and currently over 8,000 products are distributed through the Company's wholesale distribution network. For more information, please visit www.china-bct.com.

Company Contact:
Ms. Shelly Zhang, Chief Financial Officer 
China BCT Pharmacy Group, Inc.                    
Email: [email protected]   
Tel: (86) 772-363-8318      
Website: www.china-bct.com

Investor Relations Contact:
Mark Collinson, Partner
CCG Investor Relations
Email: [email protected]  
Tel: +1-310-954-1343
www.ccgirasia.com

SOURCE China BCT Pharmacy Group, Inc.